ResMed Inc. (RMD) ist ein börsennotiertes Unternehmen im Gesundheitswesen Sektor, tätig in der Medical - Instruments & Supplies Branche. Der Hauptsitz des Unternehmens ist in San Diego, CA, United States. Der aktuelle CEO ist Michael J. Farrell.
RMD hat IPO-Datum 1995-06-02, 9,980 Vollzeitbeschäftigte, gelistet an der NYSE, eine Marktkapitalisierung von $33.67B.
ResMed Inc. is a global medical device and cloud-based software company headquartered in San Diego, California, operating across two primary segments: Sleep and Respiratory Care, and Software as a Service. The company develops and manufactures a comprehensive portfolio of products including ventilation devices, diagnostic equipment, mask systems, and accessories for treating respiratory disorders and sleep apnea, as well as cloud-based informatics solutions such as AirView for remote patient monitoring and myAir for personalized therapy management. ResMed also provides out-of-hospital software platforms including Brightree for business management, MatrixCare for care management in senior living and skilled nursing facilities, and HEALTHCAREfirst for home health and hospice agencies offering electronic health records and billing services. The company markets its products to sleep clinics, hospitals, home healthcare providers, and other medical institutions through a network of distributors and direct sales representatives across approximately 140 countries. Founded in 1989, ResMed has established itself as a leader in digital health and out-of-hospital care solutions.
